Cargando…

Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression

Neoplasms of the lungs are the leading cause of cancer incidence and mortality worldwide. Although immunotherapy has increased the overall survival of patients with lung cancer, there is the need to improve this treatment. At this regard, blood lipid levels are thought to be linked to cancer risk an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartmann, Philipp, Trufa, Denis I., Hohenberger, Katja, Tausche, Patrick, Trump, Sonja, Mittler, Susanne, Geppert, Carol I., Rieker, Ralf J., Schieweck, Oliver, Sirbu, Horia, Hartmann, Arndt, Finotto, Susetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079859/
https://www.ncbi.nlm.nih.gov/pubmed/37024569
http://dx.doi.org/10.1038/s41598-023-31575-y
_version_ 1785020797115432960
author Hartmann, Philipp
Trufa, Denis I.
Hohenberger, Katja
Tausche, Patrick
Trump, Sonja
Mittler, Susanne
Geppert, Carol I.
Rieker, Ralf J.
Schieweck, Oliver
Sirbu, Horia
Hartmann, Arndt
Finotto, Susetta
author_facet Hartmann, Philipp
Trufa, Denis I.
Hohenberger, Katja
Tausche, Patrick
Trump, Sonja
Mittler, Susanne
Geppert, Carol I.
Rieker, Ralf J.
Schieweck, Oliver
Sirbu, Horia
Hartmann, Arndt
Finotto, Susetta
author_sort Hartmann, Philipp
collection PubMed
description Neoplasms of the lungs are the leading cause of cancer incidence and mortality worldwide. Although immunotherapy has increased the overall survival of patients with lung cancer, there is the need to improve this treatment. At this regard, blood lipid levels are thought to be linked to cancer risk and thus a preventive intervention through regulation of the nutrition of patients with lung cancer is gaining much attention. In this study, we therefore asked about the contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression. We measured different serum lipids and analyzed cholesterol synthesis enzymes 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) and acetyl-coenzyme A cholesterol acetyltransferase 1 (ACAT1) as well as the cholesterol cellular export protein ATP-binding cassette (ABC) A-1 mRNA by quantitative PCR (qPCR) in the control and tumoral regions of post-surgery lung tissues to analyze the accumulation of cholesterol in cancer cells in a cohort of patients with lung adenocarcinoma (LUAD). We found that triglycerides in serum directly correlated with the body mass index (BMI) in patients with LUAD. By contrast, we found that high-density lipoprotein (HDL) cholesterol inversely correlated with the BMI, C-reactive protein (CRP) and overall survival and total cholesterol inversely correlated with the tumor diameter, serum CRP and overall survival in these LUAD patients. Functionally, the role of cholesterol is indispensable for the growth and development of normal animal cells where it is tightly regulated. Excess of cellular cholesterol regulated by HMGCR is converted to cholesteryl esters by the enzyme ACAT1 and exported extracellularly by the cholesterol transporter ABCA1. Here we found HMGCR and ACAT1 upregulated and ABCA1 downregulated in the lung’s tumoral region of our LUAD cohort, indicating cholesterol dysregulated cellular export in lung tumor cells.
format Online
Article
Text
id pubmed-10079859
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100798592023-04-08 Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression Hartmann, Philipp Trufa, Denis I. Hohenberger, Katja Tausche, Patrick Trump, Sonja Mittler, Susanne Geppert, Carol I. Rieker, Ralf J. Schieweck, Oliver Sirbu, Horia Hartmann, Arndt Finotto, Susetta Sci Rep Article Neoplasms of the lungs are the leading cause of cancer incidence and mortality worldwide. Although immunotherapy has increased the overall survival of patients with lung cancer, there is the need to improve this treatment. At this regard, blood lipid levels are thought to be linked to cancer risk and thus a preventive intervention through regulation of the nutrition of patients with lung cancer is gaining much attention. In this study, we therefore asked about the contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression. We measured different serum lipids and analyzed cholesterol synthesis enzymes 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) and acetyl-coenzyme A cholesterol acetyltransferase 1 (ACAT1) as well as the cholesterol cellular export protein ATP-binding cassette (ABC) A-1 mRNA by quantitative PCR (qPCR) in the control and tumoral regions of post-surgery lung tissues to analyze the accumulation of cholesterol in cancer cells in a cohort of patients with lung adenocarcinoma (LUAD). We found that triglycerides in serum directly correlated with the body mass index (BMI) in patients with LUAD. By contrast, we found that high-density lipoprotein (HDL) cholesterol inversely correlated with the BMI, C-reactive protein (CRP) and overall survival and total cholesterol inversely correlated with the tumor diameter, serum CRP and overall survival in these LUAD patients. Functionally, the role of cholesterol is indispensable for the growth and development of normal animal cells where it is tightly regulated. Excess of cellular cholesterol regulated by HMGCR is converted to cholesteryl esters by the enzyme ACAT1 and exported extracellularly by the cholesterol transporter ABCA1. Here we found HMGCR and ACAT1 upregulated and ABCA1 downregulated in the lung’s tumoral region of our LUAD cohort, indicating cholesterol dysregulated cellular export in lung tumor cells. Nature Publishing Group UK 2023-04-06 /pmc/articles/PMC10079859/ /pubmed/37024569 http://dx.doi.org/10.1038/s41598-023-31575-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hartmann, Philipp
Trufa, Denis I.
Hohenberger, Katja
Tausche, Patrick
Trump, Sonja
Mittler, Susanne
Geppert, Carol I.
Rieker, Ralf J.
Schieweck, Oliver
Sirbu, Horia
Hartmann, Arndt
Finotto, Susetta
Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression
title Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression
title_full Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression
title_fullStr Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression
title_full_unstemmed Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression
title_short Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression
title_sort contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079859/
https://www.ncbi.nlm.nih.gov/pubmed/37024569
http://dx.doi.org/10.1038/s41598-023-31575-y
work_keys_str_mv AT hartmannphilipp contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT trufadenisi contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT hohenbergerkatja contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT tauschepatrick contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT trumpsonja contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT mittlersusanne contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT geppertcaroli contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT riekerralfj contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT schieweckoliver contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT sirbuhoria contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT hartmannarndt contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression
AT finottosusetta contributionofserumlipidsandcholesterolcellularmetabolisminlungcancerdevelopmentandprogression